Anti-Amyloid-β Protein agents for the treatment of Alzheimer’s Disease: An update on emerging drugs

Madia Lozupone,Vincenzo Solfrizzi,Francesca D’Urso,Ilaria di Gioia,Rodolfo Sardone,Vittorio Dibello,Roberta Stallone,Angelo Liguori,Chiara Ciritella,Antonio Daniele,Antonello Bellomo,Davide Seripa,Francesco Panza

Anti-Amyloid-β Protein agents for the treatment of Alzheimer’s Disease: An update on emerging drugs

2020

Madia Lozupone
Vincenzo Solfrizzi
Francesca D’Urso
Ilaria di Gioia
Rodolfo Sardone
Vittorio Dibello
Roberta Stallone
Angelo Liguori
Chiara Ciritella
Antonio Daniele
Antonello Bellomo
Davide Seripa
Francesco Panza

Currently available Alzheimer’s disease (AD) therapeutics are only symptomatic, targeting cholinergic and glutamatergic neurotransmissions. Several putative disease-modifying drugs in late-stage cl...

Keywords:

Pharmacology
Levetiracetam
Cholinergic
Monoclonal antibody
Gantenerumab
Medicine
Disease
Solanezumab
Aducanumab
Glutamatergic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

156

References

Citations